First Canadian Bell palsy guideline

The first Canadian guideline for Bell palsy, facial weakness or paralysis caused by facial nerve damage, is aimed at helping physicians manage and treat patients during the acute phase as well as recovery. The guideline, published in CMAJ (Canadian Medical Association Journal), is based on the growing body of recent evidence on the condition.

Bell palsy is damage to the that results in sudden weakness or of one side of the face. It can come on suddenly with symptoms such as drooping of the face and eyelids, twitching, and others that may include mild or total paralysis.

"Although many patients with Bell palsy will experience improvement in their facial nerve function without treatment, persistent facial weakness can have implications for quality of life," writes Dr. John de Almeida and members of the Bell Palsy Working Group. "Choosing the correct treatment options for suitable patients can optimize the likelihood of recovery."

People with mild paralysis have higher rates of recovery than those who are severely affected. Because about 1 in 60 people will be affected over the course of their lifetime, it is important for to know how to manage this illness.

"Establishing the correct diagnosis is imperative to avoid missing another treatable condition," write the authors.

Key recommendations:

  • corticosteroids for all patients with Bell palsy to help reduce involuntary facial spasms
  • combined use of antivirals and corticosteroids in patients with severe to complete paralysis but not in patients with mild to moderate paralysis
  • no antiviral treatment alone
  • for patients who do not improve or whose symptoms worsen, referral to a specialist
  • imaging for patients who do not improve to determine if there are other causes of the weakness.

The guideline is neutral on whether physiotherapy is effective for acute weakness, but it suggests that it may help patients with persistent weakness.

"The guideline was timely given recent meta-analyses of data and recent RCTs [randomized controlled trials]," says Dr. de Almeida. "We hope this new guideline will help physicians in Canada and beyond manage Bell palsy ."

More information: www.cmaj.ca/lookup/doi/10.1503/cmaj.131801

Related Stories

AAO-HNSF clinical practice guideline: Bell's palsy

date Nov 04, 2013

A multidisciplinary clinical practice guideline to improve the accurate and efficient diagnosis and treatment of Bell's palsy was published Monday in the journal Otolaryngology–Head and Neck Surgery. The guideline is int ...

Recommended for you

Genetic test for inherited kidney diseases developed

date 13 minutes ago

Many kidney disorders are difficult to diagnose. To address this problem, scientists and clinicians have developed a diagnostic test that identifies genetic changes linked to inherited kidney disorders. This ...

Diagnosing infectious diseases at the point-of-care

date 40 minutes ago

A major problem with current testing for infectious diseases in Africa is that it focuses on individual diseases and cannot reliably discriminate between them. Since most infectious diseases have the same ...

Fracture liaison services prevent fractures and save lives

date 1 hour ago

Using a simulation model, Swedish researchers have shown that the implementation of Fracture Liaison Services (FLS) could considerably reduce the human and healthcare costs associated with osteoporotic fractures. The results ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.